Non-Specific PAF Binding to Embryonal F9 Cells and Prostacyclin Synthesis in Human Umbilical Vein Endothelial Cells

  • Ruth-Maria Korth
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 416)


The platelet activating factor (Paf) is chemically 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine with saturated1 or non-saturated alkyl groups in position 1 of the molecule2–4.


Human Umbilical Vein Endothelial Cell Prostacyclin Synthesis Royal North Shore Hospital Washed Human Platelet Collagenase mRNA 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Benveniste, J. Paf-acether (platelet-activating factor). In: Advances in Prostaglandin, Thromboxane, and Leukotriene Research (Eds. Samuelsson B., Wong P.Y.-K. and Sun F.F. ) pp. 355–358, Raven Press, New York, 1989.Google Scholar
  2. 2.
    Korth, R., Hillmar, I., Muramatsu, T. and Zöllner, N. 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholines: Influence on aggregation and [3H]serotonin release of human thrombocytes. Chem. Phys. Lipids 33: 47–53, 1983.PubMedCrossRefGoogle Scholar
  3. 3.
    Korth, R., Mangold, H.K., Muramatsu, T. and Zöllner, N. Unsaturated 1-O-alkyl-2-acetyl-sn-glycero-3phosphocholines (unsaturated platelet-activating factor): Aggregation of human platelets after incubation with indomethacin, creatinephosphate/creatinephosphokinase, xylocain and hirudine, and serotonin release after incubation with indomethacin. Chem. Phys. Lipids 36: 209–214, 1985.PubMedCrossRefGoogle Scholar
  4. 4.
    Korth, R., Riess, H., Brehm, G. and Hiller, E. Unsaturated platelet-activating factor: Influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes.Thrombos. Res. 41: 699–706, 1986.Google Scholar
  5. 5.
    Ryan, J.P., O’Neill, C. and Wales, R.G. Oxidative metabolism of energy substrates by preimplantation mouse embryos in the presence of platelet-activating factor J. Reprod. Fert. 89: 301–307, 1990.CrossRefGoogle Scholar
  6. 6.
    ’ Neill, C., Ryan, J.P., Collier, M., Saunders, D.M., Ammit, A.J., and Pike, I.L. Supplementation of in-vitro fertilization culture medium with platelet activating factor. The Lancet ii: 769–772, 1989.Google Scholar
  7. 7.
    Miwa, M., Miyake, T., Yamanaka, T., Sugatani, J., Suzuki, Y., Sakata, S., Araki, Y. and Matsumoto, M. Characterization of serum platelet-activating factor (PAF) acetylhydrolase: correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J. Clin. Invest. 82, 1983–1991, 1988.PubMedCrossRefGoogle Scholar
  8. 8.
    Korth, R., Hirafuji, M., Bidault, J., Canton, B., Russo-Marie, M. and Benveniste, J. Comparison between Paf-acether receptors on intact washed human platelets and human endothelial cells in culture. In: Vascular Endothelium. Receptors and transduction mechanisms (Eds. Catravas, J.D., Gillis, C.N. and Ryan, U.S. ), pp 89–98, Plenum press New York and London, 1989.Google Scholar
  9. 9.
    Nakayama, R., Yasuda, K., Okumura, T. and Saito, K. Effect of 17ß-estradiol on PAF and prostaglandin levels in oophorectomized rat uterus. Biochim. Biophys. Acta 1085: 235–240, 1991.PubMedCrossRefGoogle Scholar
  10. 10.
    Bazan, H.E.P., Tao, Y. and Bazan, N.G. Platelet-activating factor induces collagenase expression in corneal epithelial cells. Proc. natl. Acad. Sci. 90: 8688–8682, 1993.CrossRefGoogle Scholar
  11. 11.
    l. Korth, R., Hirafuji, M., Lalau Keraly, C., Delautier, D., Bidault, J. and Benveniste, J. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells. Brit. J. Pharmacol. 98: 653–661, 1989.CrossRefGoogle Scholar
  12. 12.
    Korth, R. and Middeke, M. Long time incubation of monocytic U 937 cells with LDL increases specific Paf-acether binding and the cellular acetylhydrolase activity. Chem. and Phys. Lipids 59: 207–213, 1991.CrossRefGoogle Scholar
  13. 13.
    Korth, R., Zimmermann, K. and Richter, W.O. Lipoprotein-associated paf (LA-paf) was found in washed human platelets and monocyte/macrophage like U 937 cells. Chem. and Phys. Lipids 72: 109–119, 1994.CrossRefGoogle Scholar
  14. 14.
    Korth, R.M., Hirafuji, M., Benveniste, J., and Russo-Marie, F. Human umbilical vein endothelial cells: specific binding of platelet-activating factor and cytosolic calcium flux. Biochem. Pharmacology 49: 1793–1799, 1995.CrossRefGoogle Scholar
  15. 15.
    Korth R.-M. Verwendung von paf-Acether-Antagonisten zur Herstellung eines Arzneimittels und Verfahren zu deren Wirksamkeitsbestimmung. Europäische Patentschrift 88117022. 9, 1988.Google Scholar
  16. 16.
    D’Humière, S.D., Russo-Marie, F. and Vargaftig, B.B. Paf-acether induced synthesis of prostacyclin by human endothelial cells. Eur. J. Pharmacol. 131: 13–19, 1986.CrossRefGoogle Scholar
  17. 17.
    American Type Culture Collection, 6th edition, p 167, 1988.Google Scholar
  18. 18.
    Korth R. and Benveniste J. BN 52021 displaces 3H-Paf-acether from, and inhibits its binding to intact human platelets. Eur. J. Pharmacol. 142: 331–341, 1987.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Ruth-Maria Korth
    • 1
  1. 1.Forschung in der Allgemeinmedizin FIDAMünchenGermany

Personalised recommendations